The risk of breast cancer following reproductive surgery

European Journal of Cancer

Volumn 35, Issue 1, 1999, Pages 97-101

  Kreiger, N ^a,b   Sloan, M ^a   Cotterchio, M ^b   Kirsh, V ^b  

^a CANCER CARE ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Breast cancer; Cohort study; Gynaecological surgery

Indexed keywords

ESTROGEN;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; FOLLOW UP; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVARIECTOMY; PRIORITY JOURNAL; SALPINGECTOMY; UTERINE TUBE LIGATION;

ADOLESCENT; ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033041105     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00343-8     Document Type: Article

References (27)

1. Shin MH, Kim DH, Lee HK, et al. The effect of tubal ligation on the protection from breast cancer: a case-control study in Korea (abstract). Am J Epidemiol 1996, 143, 1 June Suppl., S58.
2. Brinton L.A., Schairer C., Hoover R.N., Fraumeni J.F. Jr. Menstrual factors and risk of breast cancer. Cancer Invest. 6:1988;245-254.
3. Irwin K.L., Lee N.C., Peterson H.B., et al. Hysterectomy, tubal ligation, and the risk of breast cancer. Am J Epidemiol. 127:1988;1192-1201.
4. Schairer C., Persson I., Falkeborn M, et al. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer. 70:1997;150-154.
5. Parazzini F., Braga C., LaVecchia C., et al. Hysterectomy, oophorectomy in premenopause, and risk of breast cancer. Fertil Steril. 90:1997;453-456.
6. Trichopoulos D., MacMahon B., Cole P. Menopause and breast cancer risk. J Nat Cancer Inst. 48:1972;605-613.
7. Kreiger N., Sloan M., Cotterchio M., Parsons P. Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol. 26:1997;710-715.
8. Statistics Canada, Health Division, Nosology Reference Centre. Canadian Classification of Diagnostic, Therapeutic and Surgical Procedures (CCSP). Ottawa, Ministry of Supply and Services Canada, 1986, Catalogue 82-562E; 8-2301-507.
9. Coleman MP, Herman C, Douglas A. Person-years (PYRS): A FORTRAN program for cohort analysis. Lyon, France, International Agency for Research on Cancer, 1989.
10. Brett K.M., Madans J.H. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol. 145:1997;536-545.
11. Kelsey J.L., Horn-Ross P. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev. 15:1993;7-16.
12. Cattanach J. Oestrogen deficiency after tubal ligation. Lancet. 1:1985;847-849.
13. Lethbridge D.J. Post-tubal Sterilization Syndrome. Nursing Scholarship. 24:1992;15-18.
14. Hakverdi A.U., Taner C.E., Erden A.C., Satici Ö. Changes in ovarian function after tubal sterilization. Adv in Contraception. 10:1994;51-56.
15. Alvarez F., Faundes A., Brache V., Tejada A.S., Segal S. Prospective study of the pituitary-ovarian function after tubal sterilization by the pomeroy or uchida techniques. Fertility and Sterility. 51:1989;604-608.
16. Rivera R., Gaitan J.R., Ruiz R., et al. Menstrual patterns and progesterone circulating levels following different procedures of tubal occlusion. Contraception. 40:1989;157-169.
17. Thranov I., Hertz J.B., Kjer J.J., et al. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips. Fertility and Sterility. 57:1992;751-755.
18. Siddle N., Sarrel P., Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertility and Sterility. 47:1987;94-100.
19. Stone E.C., Dickey R.P., Mickal A. The acute effect of hysterectomy on ovarian function. Am J Obstet Gynecol. 121:1975;193-197.
20. Bukovsky I., Halperin R., Schneider D., Golan A., Hertzianu I., Herman A. Ovarian function following abdominal hysterectomy with and without unilateral oophorectomy. Eur J Obstet and Gynecology. 58:1995;29-32.
21. Robles S.C., Marrett L.D., Clarke E.A., Risch H.A. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 41:1988;495-501.
22. Meilahn E.N., Matthews K., Egeland G., et al. Characteristics of women with hysterectomies. Maturitas. 11:1989;319-329.
23. Tavani A., Braga C., La Vecchia C., et al. Attributable risks for breast cancer in Italy: education, family history and reproductive and hormonal factors. Int J Cancer. 70:1997;159-163.
24. Hulka B., Liu E., Lininger R. Steroid hormones and risk of breast cancer. Cancer. 74:1994;1111-1124.
25. Colditz G.A., Hankinson S.E., Hunter D.J., et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Eng J Med. 332:1995;1589-1593.
26. Steinberg K.K., Smith S.J., Thacker S.B., Stroup D.F. Breast cancer risk and duration of estrogen use: the role of study design in meta-analysis. Epidemiol. 5:1994;415-421.
27. Naylor D, Anderson G, Goel V. The ICES Practice Atlas, Patterns of Health Care in Ontario, Institute for Clinical Evaluative Studies, Toronto, Vol. 1, 1994, 118-121.